| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| Gene symbol | CSH1 | Synonyms | CS-1, CSA, CSMT, GHB3, PL, hCS-1, hCS-A | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q23.3 | dbXrefs | |
| Description | chorionic somatomammotropin hormone 1 | ||||
| GTO ID | GTC2239 |
| Trial ID | NCT04156269 |
| Disease | Multiple Myeloma |
| Altered gene | BCMA|CS1 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | BCMA/CS1 cCAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Unknown |
| Title | BCMA-CS1 Compound CAR (cCAR) T Cells for Relapsed/Refractory Multiple Myeloma |
| Year | 2018 |
| Country | United States |
| Company sponsor | iCell Gene Therapeutics |
| Other ID(s) | ICG182-001 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||